We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Adalimumab
Australian Public Assessment Report
Device/Product Name
Humira
Active ingredients
Adalimumab
AusPAR Date
Published
Submission Number
PM-2012-02255-3-3
Submission Type
Extension of indications
Decision
Withdrawn